🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Big congratulations to Kricket! So fortunate to have her as my mentor and role model!

Congrats to Radhika Agarwal and team on this great study!

Wonderful evening in Boston North End with members of the extended Olson Lab family. Proud of you all! Keep on discovering. ⁦Mol Biology Dept UTSW⁩

6 Weeks Left to Apply for the #AVCIA Catalyst Award! #postdocs #ECR #FundingOpportunity #singleventricle 💲 Award supports up to $1.2M over 6 years 🗓️ LOI due March 16th Learn more and download the RFP here: additionalventures.org/initiatives/bi…

Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation. Study by great friends Harvard Medical School Spearheaded by Gabriela Venturini! frontiersin.org/articles/10.33…

Excited to report our collaborative efforts to better understand mechanisms behind beneficial effects of ARB in early-stage HCM! ahajournals.org/doi/abs/10.116… Thanks to christoffer vissing @sday_hcm Henning Bundgaard Anjali Owens Carolyn Ho Brigham and Women’s Cardiovascular Life Science Brigham and Women’s Research and many others

In Opinion “Today, I will explain to my healthy transplanted heart why, in what may be a matter of days or weeks at best, she — well, we — will die,” writes Amy Silverstein, an author, in a guest essay. nyti.ms/3V0iodr

We at the CureHeart team are looking for an enthusiastic colleague to help us test and design genetic cures for inherited heart muscle diseases. We are working with human iPSCs and cutting edge CRISPR/Cas9 technologies to design these treatments. tinyurl.com/CureHeart1

A major adverse effect of statins is myopathy (known since 1980). Now genetics have shed light on this association. Two independent teams have recently discovered that recessive mutations in HMGCR cause a severe form of muscular disease in humans. A 🧵 for genetics lovers.

Acto3D: an open-source user-friendly volume rendering software for high-resolution 3D fluorescence imaging in biology Read this Techniques and Resources Article by Naoki Takeshita, Kenta Yashiro Kenta Yashiro and colleagues: journals.biologists.com/dev/article/15…

The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM 3 presentations in 3 threads - follow along This is the first presentation by Martin Maron, MD sharing the primary results Follow along #CardioTwitter #HeartFailure2024

Just in time for #ChildhoodCancerAwarenessMonth, the Voit lab is hiring! We looking for interested and interesting post-doc candidates to join our team UT Southwestern Medical Center focused at the intersection of hematopoiesis, cancer biology, and gene therapy. tinyurl.com/Voit-lab-postd…

Very excited to share our AHA Science Advisory where we discuss current promises and limitations of gene therapy in CVD. It was such an honor to work with @APLandstrom Svati Shah Joseph C Wu, MD, PhD, Kricket, AHA Science American Heart Association and Circulation Brigham and Women’s Cardiovascular Life Science Brigham and Women's Hospital #GeneTherapy

Dr. Meraj Neyazi, MD educating us on single cell transcriptomic signatures of cardiac sarcoidosis and fantastic questions by the audience! Dr. Gavin Oudit Martin Beyer UKE Hamburg Harvard Medical School AHA Science American Heart Association #AHA2024 #sarcoidosis

Thrilled to see this collaborative effort published! Many thanks to my brilliant collaborators and mentors

Excited to share our latest publication where we identified a novel and essential role of TTN enhancer. Thanks to Meraj Neyazi, MD Konstantinos Gkatzis Zolt Arany Arun Sharma Christopher Toepfer Dr. Gavin Oudit williampu @AxelVisel.bsky.social Brigham and Women's Hospital Harvard Medical School Brigham and Women’s Cardiovascular Life Science and all others #Genetics

Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes | PNAS pnas.org/doi/10.1073/pn…